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Vector arthropods control arbovirus replication and spread through antiviral innate immune
responses including RNA interference (RNAi) pathways. Arbovirus infections have been
shown to induce the exogenous small interfering RNA (siRNA) and Piwi-interacting RNA
(piRNA) pathways, but direct antiviral activity by these host responses in mosquito cells has
only been demonstrated against a limited number of positive-strand RNA arboviruses. For
bunyaviruses in general, the relative contribution of small RNA pathways in antiviral
defences is unknown.
Methodology/Principal Findings
The genus Orthobunyavirus in the Bunyaviridae family harbours a diverse range of mos-
quito-, midge- and tick-borne arboviruses. We hypothesized that differences in the antiviral
RNAi response in vector versus non-vector cells may exist and that could influence viral
host range. Using Aedes aegypti-derived mosquito cells, mosquito-borne orthobunya-
viruses and midge-borne orthobunyaviruses we showed that bunyavirus infection com-
monly induced the production of small RNAs and the effects of the small RNA pathways on
individual viruses differ in specific vector-arbovirus interactions.
Conclusions/Significance
These findings have important implications for our understanding of antiviral RNAi pathways
and orthobunyavirus-vector interactions and tropism.
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Author Summary
A number of orthobunyaviruses such as Oropouche virus, La Crosse virus and Schmallen-
berg virus are important global human or animal pathogens transmitted by arthropod
vectors. Further understanding of the antiviral control mechanisms in arthropod vectors
is key to developing novel prevention strategies based on preventing transmission. Antivi-
ral small RNA pathways such as the exogenous siRNA and piRNA pathways have been
shown to mediate antiviral activity against positive-strand RNA arboviruses, but informa-
tion about their activities against negative-strand RNA arboviruses is critically lacking.
Here we show that in Aedes aegypti-derived mosquito cells, the antiviral responses to mos-
quito-borne orthobunyaviruses is largely mediated by both siRNA and piRNA pathways,
whereas the piRNA pathway plays only a minor role in controlling midge-borne orthobu-
nyaviruses. This suggests that vector specificity is in part controlled by antiviral responses
that depend on the host species. These findings contribute significantly to our under-
standing of arbovirus-vector interactions.
Introduction
Orthobunyaviruses are endemic in tropical and subtropical regions worldwide and are trans-
mitted by mosquitoes, midges, ticks or other arthropods. The Orthobunyavirus genus within
the Bunyaviridae family comprises at least 30 viruses that can cause disease in humans, includ-
ing Oropouche virus (OROV; febrile illness), La Crosse virus (LACV; encephalitis) and Ngari
virus (haemorrhagic fever) [1]. In addition, infection by orthobunyaviruses such as Cache Val-
ley virus (CVV) and Schmallenberg virus (SBV) can lead to disease in animals [2].
Bunyamwera virus (BUNV) is the prototype virus of both the Orthobunyavirus genus and
the family. Like most viruses in the genus, the BUNV genome possesses a tripartite, single-
stranded negative sense RNA genome, in which the small (S) segment encodes the nucleo-
capsid (N) protein and the nonstructural protein NSs in overlapping reading frames, the
medium (M) segment encodes a viral glycoprotein precursor (in the order Gn-NSm-Gc) for
two envelope glycoproteins Gn, Gc and a nonstructural protein NSm, and the large (L) seg-
ment encodes the RNA-dependent RNA polymerase. This genome structure is generally
reflected by most orthobunyaviruses with some differences for example in the presence or
length of NSs [1].
BUNV was originally isolated from Aedes spec. mosquitoes in the Semliki Forest in Uganda
in 1943 [3] but has since also been found in Culex spec. and Mansonia spec. (see [4] and refer-
ences on BUNV therein) and Ochlerotatus spec. [5]. BUNV infections cause febrile illness and
(rarely) encephalitis in humans in Sub-Saharan Africa, in particular in Nigeria and the Central
African Republic, with wild rodents likely to be serving as amplifying reservoir [6]. Cache Val-
ley virus (CVV) belongs to the Bunyamwera serogroup and is enzootic throughout North and
South America [7, 8]. It was first isolated from Culiseta inornata mosquitoes in the Cache Val-
ley in Utah, United States of America in 1956 [8], and has since been shown to be transmitted
by mosquitoes of the Culiseta, Anopheles, Aedes, Culex and Ochleratatus genera [9, 10]. A small
number of CVV infections in humans have been reported [11–13], where infection rarely
leads to serious disease. In ruminants, including sheep and cattle, CVV causes spontaneous
abortions and multiple congenital malformations [14–16]. Large mammals including deer,
horses and sheep are known to serve as amplifying hosts [6].
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In addition to mosquito-borne orthobunyaviruses some members of the genus are exclu-
sively transmitted by biting midges (e.g. SBV, OROV and Sathuperi virus [SATV]) [17–22],
ticks (Tete group viruses Bahig and Matruh) [23] or are mosquito/insect-specific [24, 25].
SBV and SATV are closely related orthobunyaviruses of the Simbu serogroup. SBV was first
discovered in 2011 in Germany and the Netherlands [26] and infections have since been
reported in many European countries [27]. Infections can lead to reduced milk yield, fever,
fetal malformations and abortions in ruminants (primarily sheep, goats and cattle) [26, 28];
human infections have not been reported. SATV was isolated from mosquitoes in India in
1957 [29], and was later detected in cattle and biting midges in Nigeria [30, 31]. More recently,
SATV was detected in Japan in 1999 [32]. To date little information is available on its pathoge-
nicity in ruminants [22]. Both SBV and SATV are transmitted by Culicoides sp. biting midges
[22, 31, 33–35].
The exogenous small interfering (exo-si) RNA and Piwi-interacting (pi)RNA pathways
have previously been described as important mosquito antiviral responses limiting the replica-
tion of positive-strand RNA flaviviruses and togaviruses [36, 37]. The activity of the exo-
siRNA pathway is mediated by two key proteins, the endoribonuclease Dicer-2 (Dcr2) and
Argonaute-2 (Ago2). Dcr2 cleaves long virus-derived double-stranded RNAs (dsRNAs) into
21 nucleotides (nt) long small interfering RNA (viRNA) duplexes. These viRNAs are then
incorporated into the multiprotein RNA-induced silencing complex (RISC), where presum-
ably one strand is retained (guide strand) by Ago2 to detect, bind and catalyze the degradation
of complementary single-stranded (ss)RNA such as viral mRNA. Indeed, 21 nt viRNAs were
produced in mosquitoes or mosquito-derived cell lines upon infection with several arbovi-
ruses, for example flaviviruses (dengue virus, DENV; West Nile virus, WNV), alphaviruses of
the Togaviridae family (chikungunya virus, CHIKV; Semliki Forest virus, SFV; Sindbis virus,
SINV; o’nyong’nyong virus, ONNV), bunyaviruses (Rift Valley fever virus, RVFV; and SBV)
as well as reoviruses (bluetongue virus, BTV) [38–42]. Silencing experiments in mosquitoes
have confirmed the antiviral activity of the exo-siRNA pathway against DENV, SINV, CHIKV
and ONNV in vivo [42–46].
In addition to the exo-siRNA pathway, the piRNA pathway has been shown to be a contrib-
utor to antiviral immunity in mosquitoes or derived cells [38, 47]. In Drosophila, the piRNA
pathway is involved in the epigenetic regulation of the expression of transposable elements
(TE) in the germline, and thus preserves the genome integrity [48–51]. However, PIWI pro-
teins have also been detected in somatic cells [49, 52–54]. The production of transposon-spe-
cific piRNAs is complex and relies on proteins of PIWI clade, in particular Piwi, Aubergine
(Aub) and Argonaute-3 (Ago3). piRNAs are believed to be generated via a primary processing
pathway and a secondary ping-pong amplification loop [51, 52]. Primary piRNAs have a 5’ uri-
dine (U1) bias. Secondary piRNAs have a 10 nt overlap with primary piRNAs and contain an
adenine at position 10 (A10 bias). Mature piRNAs are generally 26–32 nt in length. The piRNA
pathway is functional in mosquito germline and somatic cells [38, 39, 47, 55–57]. Interestingly,
in mosquitoes a loss of Aub and a diversification of Piwi proteins has occurred [58]. This gene
diversification has been linked with a gain of function of the piRNA pathway and a new role in
antiviral immunity since the pathway has also been found to target a number of mosquito-
borne viruses including DENV, CHIKV, SFV and RVFV [38, 39, 47]. Further, in the Ae.
aegypti-derived Aag2 cell line an antiviral effect of Piwi4 against SFV has been directly demon-
strated [47]. Recently it was shown that Ago3 and Piwi5 (and Piwi6 to a lesser extent) are
needed for the generation of SINV and DENV specific piRNAs in Aag2 cells [59, 60]; however,
the viral RNA substrate that induces this pathway is unknown. Importantly, the respective
contribution of the two small RNA pathways to immune defenses against negative-sense RNA
arboviruses has not been studied. In short, little is known about the interactions of viruses and
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vectors, and antiviral responses of vectors, which may govern viral infection, dissemination
and transmission.
In this study we investigated the antiviral activities of the mosquito exo-siRNA and piRNA
pathway against two mosquito- and three midge-borne orthobunyaviruses. Using reporter
BUNV and SBV that express Nano luciferase we compared these responses in vector-virus and
non-vector-virus interactions. We performed small RNA sequencing and showed that mos-
quito as well as midge-borne viruses produce virus-specific siRNAs and piRNAs in mosquito
cells. Interestingly we found that silencing of Ago2 and Piwi4 in Aag2 cells led to increased
viral replication of mosquito-borne orthobunyaviruses, in contrast to midge-borne orthobu-
nyaviruses where only Ago2 silencing increased virus replication. Additionally, silencing of
other piRNA pathway members (Piwi5, 6 and Ago3) affected virus replication differently
depending on whether the virus was mosquito- or midge borne. These findings indicate that
RNAi pathways play a crucial role in the control of orthobunyavirus replication; however, the
piRNA pathway in Aag2 cells seems to be adapted to specific virus-vector combinations and
may have important consequences for arbovirus tropism and vector specificity.
Results
Induction of small RNA production by orthobunyaviruses in mosquito
and midge cells
Our previous work has shown that small RNAs with viRNA and piRNA characteristics are
produced in non-vector mosquito cells infected with the midge-borne SBV [40] (S1A Fig). To
determine if this is similar for a mosquito-borne virus, Ae. aegypti-derived Aag2 cells were
infected with BUNV (Fig 1A and 1B) and small RNAs were isolated, sequenced and mapped
to the virus genome and antigenome. As shown in Figs 1C and 2A, 21 nt long small RNAs
were produced from all three segments which mapped along the genome and antigenome in a
cold and hot spot pattern. For the L segment, these 21 nts viRNAs were the major small RNA
species produced. Moreover, small RNAs of 24–30 nts with piRNA-specific features (A10, U1
bias), which mapped across the genome and antigenome in a hot and cold spot pattern (Fig
2B), were produced for all three segments (Fig 2C); however, they were the major small RNA
species only for M and S segments with a bias for small RNAs mapping to the antigenome. In
contrast, 24–30 nt small RNAs mapping to the L segment had a bias for the genome (Fig 1C).
Similar results were obtained in BUNV-infected Ae. albopictus-derived U4.4 cells (S2 Fig).
To determine if similar small RNAs are produced for BUNV and SBV in midge cells; exper-
iments were repeated with infected C. sonorensis KC cells. As previously reported no piRNA-
like molecules could be detected for SBV in KC cells, in contrast, 21 nt small RNAs were
mapped to the genome and antigenome of all three segments [40] (S1B Fig). Similar results
were observed for BUNV small RNAs in infected KC cells (Fig 1D). Although small RNAs of
24–28 nts could be detected in KC cells, they lacked the piRNA-specific features (A10, U1 bias
and 10 nts overlap of sense and antisense small RNAs) (Fig 1D).
Overall, our data showed that BUNV infection induced small RNA patterns comparable
with SBV [40] in mosquito-derived cells as well as Culicoides-derived cells. In addition, differ-
ences in small RNA patterns were found between mosquito and midge cells.
Generation of BUNV reporter virus expressing Nano luciferase
Previously, luciferase expressing alphaviruses were employed to investigate the antiviral RNAi
response in arthropod cells [47, 61, 62]. To obtain similar tools for bunyaviruses, Nano lucifer-
ase (NL) expressing BUNV (BUNV-NL) and SBV (SBV-NL) were constructed in the course of
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Fig 1. BUNV growth and BUNV-specific viRNA production in Aag2 cells. (A) BUNV growth curve following infection of Aag2 cells at
MOI 1, determined by plaque assay. (B) Immunofluorescence of BUNV-infected Aag2 cells (MOI 0.01) at 48 hours p.i., using BUNV-N
specific primary antibody and Alexa 488-conjugated anti-rabbit-IgG secondary antibody (green). Nucleus stained by Dapi (blue). (C)
BUNV-specific small RNAs produced in infected Aag2 cells at 24 hours p.i. against L, M and S segments. The y axis indicates read
frequency; the x axis indicates the length of the small RNAs (nt). Red indicates the small RNAs mapping to the antigenome and green the
small RNAs mapping to the genome. (D) BUNV-specific small RNAs produced in infected KC cells at 48 hours p.i. against L, M and S
segments. The y axis indicates read frequency; the x axis indicates the length of the small RNAs. Red indicates the small RNAs mapping
to the antigenome and green the small RNAs mapping to the genome.
doi:10.1371/journal.pntd.0005272.g001
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this study. BUNV NSm protein, which is dispensable in viral replication in tissue culture, con-
sists of the ectodomain, transmembrane, cytoplasmic domain and type-II transmembrane
domain that also serves as internal Gc signal peptide [63, 64]. For BUNV-NL, the 62 residues
of the NSm cytoplasmic domain (residues 395 to 455) was replaced by the NL coding region
between residues 394 and 456, resulting in a chimeric NSm-NL fusion protein (S3A Fig).
NSm-NL has a similar molecular weight to that of N protein (28.67 versus 26.67 kDa) and was
indistinguishable from the N protein band in the protein profile of the reporter virus (S3B
Fig). BUNV-NL exhibited smaller plaque size than the wildtype virus (S3C Fig). The reporter
virus could readily infect Aag2 cells, similar to wildtype virus (S3D Fig). The SBV-NL reporter
virus was constructed in the same way as BUNV-NL and successful infection of Aag2 cells,
comparable to wildtype SBV, was verified by immunostaining (S3D Fig).
piRNA and miRNA pathways differentially affect midge- and mosquito-
borne virus infections in Aag2 cells
To assess the antiviral role of the small RNAi pathways in BUNV and SBV infected Aag2 mos-
quito cells, knockdown experiments were performed. Transcripts of the different RNAi path-
way key effectors (Ago2, exo-siRNA pathway; Ago1, miRNA pathway; Piwi4-6 and Ago3,
piRNA pathway) were silenced by transfection of sequence-specific dsRNA. The effect of the
Fig 2. BUNV-specific small RNA and piRNA-like molecules produced in infected Aag2 cells at 24 hours p.i. (A) Frequency
distribution of 21 nt small RNAs along the BUNV antigenome from the 5‘ to 3‘ (positive numbers and red), genome (negative numbers and
green) from 3‘ to 5‘. (B) Frequency distribution of 24–30 nt small RNAs along the BUNV antigenome from the 5‘ to 3‘ (positive numbers
and red), genome (negative numbers and green) from 3‘ to 5‘ (C) Relative nucleotide frequency and conservation per position of 24–30 nt
small RNAs mapping to the genome or antigenome of BUNV S, M and L segments. Sequence is represented as DNA.
doi:10.1371/journal.pntd.0005272.g002
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silencing was evaluated by BUNV-NL or SBV-NL infection at 24 hours post-transfection (p.t.)
at low MOI (0.01) and subsequent luciferase detection at 48 hours p.i. (Figs 3A, 3B, 4A and
4B); dsRNA specific to eGFP was used as negative control.
Silencing of Ago2 led to an increase in luciferase expression for both BUNV-NL and SBV-
NL (Fig 3A and 3B). In contrast, silencing of Piwi4 had no effect on SBV-NL, but resulted in
Fig 3. Effects of silencing exo-siRNA, miRNA and piRNA pathway key proteins on different orthobunyavirus infections in
Aag2 cells. Silencing of key transcripts by transfection of sequence-specific dsRNA (Ago1, Ago2, Piwi4 or eGFP as negative
control) into Aag2 cells, followed by infection at MOI 0.01 at 24 hours p.t.; BUNV-NL (A), SBV-NL (B) or CVV, SATV (C). Cells
were lysed at 48 hours p.i. and luciferase activity determined (A, B) or RNA isolated, followed by cDNA synthesis and virus specific
qRT-PCR (C). Knockdown of RNAi transcripts was verified by qRT-PCR (D). S7 was used as internal control in qRT-PCR assays.
All data were normalized to cells transfected with control dsRNA. Graphs represent three independent experiments performed in
triplicate for the luciferase assays and three independent experiments for the qRT-PCR assays. * p0.05 student t-test.
doi:10.1371/journal.pntd.0005272.g003
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an increase of BUNV-NL replication. Interestingly, silencing expression of other piRNA path-
way related genes resulted in a significant decrease of BUNV-NL (Piwi6 and Ago3 knock-
downs) and SBV-NL (Piwi5 knockdown) replication (Fig 4A and 4B). A decrease of luciferase
expression was also observed for BUNV-NL following Ago1 silencing, compared to an
Fig 4. Effects of silencing Piwi5, Piwi6 and Ago3 on BUNV-NL and SBV-NL replication in Aag2 cells. Silencing of transcripts by
transfection of sequence-specific dsRNA (Piwi5, Piwi6, Ago3 or eGFP as negative control) into Aag2 cells, followed by infection at MOI 0.01 at
24 hours p.t.; BUNV-NL (A), SBV-NL (B). Cells were lysed at 48 hours p.i. and luciferase activity determined (A-B). Knockdown of RNAi
transcripts was verified by qRT-PCR (C). S7 was used as internal control in qRT-PCR assays. All data were normalized to cells transfected
with control dsRNA. Graphs represent three independent experiments performed in triplicate for the luciferase assays and three independent
experiments for the qRT-PCR assays. * p0.05 student t-test.
doi:10.1371/journal.pntd.0005272.g004
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increase of luciferase expression for SBV-NL (Fig 3A and 3B). These results suggested differ-
ences in the ability of the piRNA and miRNA pathway to interact with BUNV and SBV.
To determine if this was virus-specific or due to vector versus non-vector arbovirus interac-
tion, silencing experiments were repeated with the mosquito-borne Cache Valley orthobunya-
virus (CVV) as well as the midge-borne Sathuperi (SATV) orthobunyaviruses after their
ability to grow in Aag2 cells was verified (S4A Fig).
Similar to BUNV, silencing of Ago2 or Piwi4 promoted CVV replication, whereas Ago1
knockdown reduced CVV replication (Fig 3C). Moreover, CVV-infected, Piwi4-silenced Aag2
cells showed cytopathic effects not observed for any of the other knockdown experiments with
this virus (S4B Fig). For midge-borne SATV, an increase in replication was observed in cells
silenced for Ago2 and Ago1. However, no significant effect on SATV replication was observed
in cells treated with Piwi4 dsRNA (Fig 3C). Successful silencing of transcripts by sequence spe-
cific dsRNAs was verified by quantitative RT-PCR (Figs 3D and 4C).
In short, Ago2 silencing led to a consistent increase in virus replication for mosquito and
midge-borne orthobunyaviruses, supporting an antiviral activity of the exo-siRNA pathway.
Similar effects were observed for Piwi4 silencing in the case of mosquito-borne viruses, but
not midge-borne viruses.
Silencing of Ago1 resulted in a decrease of replication of the tested mosquito-borne viruses,
suggesting an importance of the miRNA pathway for a successful infection in Aag2 cells for
these viruses. In contrast, silencing of Ago1 resulted in an increase of SBV and SATV, albeit
only slightly significant.
Discussion
The RNAi response is a major antiviral response in arthropods against arbovirus infection.
The activated exo-siRNA pathway plays a role in a variety of organisms, including mosquitoes
and the model insect D. melanogaster. In contrast, the antiviral activity of the piRNA pathway
and the production of viral specific piRNA molecules have been restricted to mosquitoes, espe-
cially Aedes spp. Besides, interactions between the miRNA pathway and viruses have been
reported in several organisms [65, 66], acting either pro- or antiviral. This can be by expression
changes of vector/host miRNAs or viral encoded miRNAs which can either directly target the
virus or have host/vector targets, resulting in changes of the cell environment. Previous
research has often used D. melanogaster to investigate the interaction between the insect RNAi
response and different viruses including arboviruses; however little is known about the speci-
ficity of the antiviral response in vector- or non-vector arbovirus interactions. Knockdown
experiments of key proteins of the exo-siRNA, miRNA and piRNA pathway in mosquito cells
and orthobunyavirus infection, either mosquito- or midge-borne, supports the broad antiviral
activity of the exo-siRNA pathway, based on an observed increase in virus replication upon
Ago2 silencing for all viruses used. In contrast, the miRNA pathway seemed to be only impor-
tant for virus replication in the case of a virus-vector match. miRNA expression is often species
or even tissue specific and some miRNA-arbovirus interactions have been reported [67].
Whether a similar interaction is important for BUNV and CVV infection in mosquitoes has to
be investigated in the future.
Infections with both mosquito-borne and midge-borne viruses were able to induce viral
specific piRNAs in the used mosquito cell line. However, the antiviral activity of the piRNA
pathway was only confirmed for the mosquito-borne viruses in the Piwi4 knockdown cells.
Interestingly knockdown of other piRNA pathway members indicated that they may have pro-
viral activities, knockdown of Piwi6 and Ago3 had replication suppressive effects on the mos-
quito-borne BUNV while knockdown of these proteins had no effect on the midge-borne
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SBV, whereas knockdown of Piwi5 reduced SBV replication but not BUNV replication. The
meaning and biological relevance of these observations is not yet clear. Co-silencing/infection
experiments and sequencing of virus-derived small RNAs from such cells may give clues to
how different Piwi proteins interact, their role in piRNA-like small RNA production and
potentially a hierarchy of protein effector and regulatory functions within this pathway. Per-
haps, similar to other RNA binding proteins some of these proteins are important for promot-
ing virus replication though this would require in depth analysis of RNA protein interactions
and/or protein-protein interaction studies. Little is known about the piRNA pathway in mos-
quitoes, the production of virus specific piRNAs and how/if they target the virus. Recently, it
has been shown that Piwi5 (and to a lesser extent Piwi6) and Ago3 are needed for virus-derived
piRNA production [59, 60]; however, no antiviral activity has previously been linked to these
transcripts. In contrast, Piwi4 seems not to be involved in virus-derived piRNA production
[59]; however knockdown of Piwi4 can result in antiviral activity for mosquito-borne viruses,
like SFV [47]. Similar antiviral activity of Piwi4 is observed for the mosquito-borne orthobu-
nyaviruses: CVV and BUNV, but not for midge-borne orthobunyaviruses (SBV and SATV).
This is especially striking as both the mosquito-borne BUNV as well as midge-borne SBV pro-
duce similar amounts of virus-specific piRNA molecules in infected Aag2 cells. This would
suggest that the antiviral activity of Piwi4 is species specific and either acts as an effector pro-
tein downstream of the virus specific-piRNA production or through a different as yet uniden-
tified pathway. Interestingly, no viral specific piRNAs have been reported in midges so far;
although this has only been investigated in the C. sonorensis-derived KC cell line and not
whole midges [40].
Interestingly, it has been shown that infection of mosquitoes and mosquito-derived cul-
tured cells with arboviruses can lead to generation of virus derived cDNA forms, which are
important for mosquito tolerance to virus infection and survival [68]. These DNA forms have
the potential to become the template for small RNA production and could therefore determine
the action of RNAi pathways on acute arbovirus infection. If the generation of cDNA forms in
mosquitoes and derived cells is mosquito-borne virus specific (not occurring with e.g. midge
borne viruses) is not known, but could explain the observed species specific antiviral activity of
Piwi4.
Overall, these results show the importance to investigate the antiviral RNAi response in vec-




BSR-T7/5 cells [derived from the BSR clone of baby hamster kidney cells-21 [BHK-21] and sta-
bly expressing T7 RNA polymerase [69]; a kind gift of Dr. K.K. Conzelmann, Max-von-Petten-
kofer Institut, Munich, Germany] were maintained in Glasgow minimal essential medium
(GMEM) supplemented with 10% tryptose phosphate broth (TPB), 10% fetal calf serum (FCS),
and 1 mg/mL geneticin. BHK-21 cells were maintained in GMEM supplemented with 10%
TPB, 10% newborn calf serum (NCS) and 1% penicillin/streptomycin (P/S). Sheep choroid
plexus cells (CPT-Tert) [70] were grown in Iscove’s modified Dulbecco’s media (IMDM) sup-
plemented with 10% FCS and 1% P/S. Vero E6 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) and 10% FCS. BSR-T7/5, BHK-21, CPT-Tert and Vero E6 cells were
grown at 37˚C and 5% CO2. Ae. aegypti-derived Aag2 cells were maintained in L-15 medium
supplemented with 10% TBP, 10% FCS and 1% P/S at 28˚C.
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Plasmids
Plasmids to generate full-length BUNV antigenome RNA transcripts [pT7riboBUNL(+),
pTVT7RBUNM(+), and pT7riboBUNS(+)] have been described previously [71, 72].
pTVT7RBUNM-NL was generated by PCR-directed internal deletion to replace the coding
region of the NSm cytoplasmic tail (residues 395 to 456) with that of Nano luciferase (NL). A
five amino acid linker, GASGA, was inserted between the NSm transmembrane domain
(TMD) and the N-terminus of NL. To facilitate the cloning of NL, a unique KpnI restriction
enzyme site was introduced at nt 1419 in the BUNV M segment cDNA (S3A Fig). The plas-
mids, pUCSBVST7, pUCSBVMT7 and pUCSBVLT7, used to rescue SBV have been described
previously [73]. pUCSBVT7-NL was generated through the introduction of two unique restric-
tion sites, MIuI and XhoI, in the SBV M segment (provided by M. Varela; University of Glas-
gow). The restrictions sites were used to delete 90 nt of NSm (corresponding to nt 1235–1325
in JX853180.1) and NL was subsequently cloned in the deletion site. NL is a small luciferase
subunit (19 kDa) from the deep sea shrimp Oplophorus gracilirostris with significantly
increased luminescence expression and signal half-life as well as specific activity in mammalian
cells compared to both Firefly and Renilla luciferases. NL uses a novel imidazopyrazinone sub-
strate (furimazine) [74].
Virus rescue by reverse genetics and plaque assay
Rescue experiments were performed as essentially described previously, with a modification
[75]. Briefly, BSR-T7/5 cells were transfected with a mixture of plasmids comprising 0.5 μg
each of pT7riboBUNL(+), pT7riboBUNS(+) and either TVT7RBUNM(+) or TVT7RBUNM-
NLuc cDNA. At 4 hours p.t., 2 ml growth medium was added and incubation continued for
5–11 days at 33˚C until cytopathic effect (CPE) was evident. Virus titre was determined by pla-
que assay on BSR-T7/5 cells. Cells were fixed in 4% formaldehyde and plaques stained in 0.01%
toluidine blue. The rescue of SBV-NL was performed using pUCSBVST7, pUCSBVMT7-NL
and pUCSBVLT7 as described for BUNV but with the exception that 1 μg of each plasmid was
used and that the plaque assay was performed using BHK-21 cells.
Preparation of virus working stocks
BUNV, BUNV-NL, SBV, SBV-NL, CVV and SATV stocks were grown in BHK-21 cells. Cells
were infected with viruses at a multiplicity of infection (MOI) of 0.01 PFU/cell and incubated
at 33˚C. Virus-containing cell supernatant was harvested when CPE was evident (usually 2–4
days p.i.), cleared by centrifugation and stored at -80˚C. Virus titres of BUNV and CVV were
determined by plaque assay on BHK-21 cells and those of SBV and SATV on CPT-Tert cells.
Metabolic radiolabelling and immunoprecipitation
Procedures for metabolic radiolabelling and immunoprecipitation of BUNV proteins were
described previously [76]. Briefly, at 24 hours p.i., BSR-T7/5 cells were labelled with [35S]
methionine (50 Ci) for 2 hours and then lysed, on ice, in 300 μl of non-denaturing RIPA buffer
(50 mM Tris-HCl [pH7.4], 1% Triton X-100, 300 mM NaCl, 5 mM EDTA) containing a cock-
tail of protease inhibitors (Roche). For immunoprecipitation assays, BUNV viral proteins were
immunoprecipitated with anti-BUNV antibody, a rabbit antisera raised against purified
BUNV [77] that had been conjugated to magnetic Protein A-Dynabeads (Life Technologies).
Viral proteins were analysed by SDS-PAGE under reducing conditions.
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Plaque assays in mammalian cells
The plaque phenotype of BUNV and BUNV-NL in BSR cells (routinely grown in GMEM sup-
plemented with 10% foetal calf serum at 37˚C in a 5% CO2 incubator) was investigated by pla-
que assay. Cells were seeded into 12-well plates at a density of 1.2 x 105 cells/well and left to
adhere overnight. Cells were infected with BUNV or BUNV-NL at a MOI of 0.05 and cells
were fixed with 4% formaldehyde-PBS and stained with 0.1% crystal violet blue solution at 3
days post infection.
Virus growth assays in mosquito cells
Growth of BUNV, SBV, CVV and SATV in Aag2 cells was assessed. Briefly, Aag2 cells were
seeded into 24-well plates at a density of 1.7 x 105 cells/well and left to adhere overnight. Cells
were then infected with viruses at MOI 1 (BUNV, CVV) or MOI 0.01 (SBV, SATV) and cul-
ture supernatant was harvested at different time points p.i. Viral titres were determined by pla-
que assays on BHK-21 cells (BUNV, CVV) or CPT-Tert cells (SBV, SATV).
Immunofluorescence assays
Aag2 cells were seeded into 24-well glass bottom plates at a density of 1.7 x 105 cells/well and
infected with BUNV, BUNV-NL, SBV or SBV-NL at a MOI of 0.01 for 48 hours. Cells were
fixed and stained with anti-BUNV N or–SBV N antibody [78, 79]. Goat anti-rabbit Alexa
Fluor 488 antibody (Molecular Probes) was used to detect primary antibodies and cells were
mounted using Vectashield mounting media containing DAPI (Vectorlabs). Images were
taken using the EVOS FL Cell Imaging System.
Small RNA deep sequencing
Small RNA sequencing of BUNV-infected Aag2 and U4.4 cells was carried out by Edinburgh
Genomics (University of Edinburgh) using the Illumina HighSeq 2000 platform, as previ-
ously described [40]. In short, 2.6 x 106 Aag2 cells/well were seeded into a 6-well plate and
left to adhere overnight. Cells were infected with BUNV at a MOI of 10. At 24 hours p.i.,
RNA was isolated from individual wells using 1 ml TRIzol (Life Technologies) followed by
purification, sequencing, analysis and mapping of virus specific small RNAs using viRome
[80]. Small RNA sequences were submitted to the European Nucleotide Archive (accession
number PRJEB15203). Data for SBV are referenced under [40]. The actual number of reads
for each experiment is shown S1 Table.
Silencing of RNAi pathway components
Silencing of Ae. aegypti Ago2, Piwi4, and Ago1 was performed in Aag2 cells using dsRNAs as
previously described [81]. dsRNA targeting eGFP was used as control. Silencing of transcripts
was confirmed by qRT-PCR using Fast SYBR Green Master Mix (Applied Biosystems) and the
corresponding primers [S2 Table; [81]]; on an ABI 7500 Fast real-time PCR instrument. Ae.
aegypti S7 ribosomal transcript was used as housekeeping gene for relative quantification as
previously described [81]. At 24 hours p.t., cells were infected with BUNV-NL, SBV-NL, CVV
or SATV at a MOI of 0.01. At 48 hours p.i. cells were either lysed in passive lysis buffer and NL
luminescence was measured (BUNV-NL and SBV-NL) or RNA was isolated using TRIzol
(CVV and SATV), followed by cDNA production and qRT-PCR analysis. cDNA synthesis was
performed using random hexamer primers (Promega) and SuperScript III reverse transcrip-
tase (Life Technologies). qRT-PCR was performed using Fast SYBR Green Master Mix using
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corresponding primers (S2 Table). Ae. aegypti S7 ribosomal transcript was used as housekeep-
ing gene.
Supporting Information
S1 Fig. SBV-specific small RNAs production in infected Aag2 and KC cells. Size distribu-
tion of SBV-specific small RNAs in Ae. aegypti-derived Aag2 cells at 48 hours p.i. (A) or C.
sonorensis KC cells (B) at 24 hours p.i. The y-axis indicates read frequency; the x-axis indicates
the length of the small RNAs (nt). Red indicates the small RNAs mapping to the antigenome
and green the small RNAs mapping to the genome of L, M and S segments.
(TIF)
S2 Fig. BUNV-specific small RNAs in infected U4.4 cells at 24 hours p.i. against L, M and S
segment. (A) Size distribution of BUNV-specific small RNAs. The y axis indicates read fre-
quency; the x axis indicates the length of the small RNAs (nt). Red indicates the small RNAs
mapping to the antigenome and green the small RNAs mapping to the genome. (B) Relative
nucleotide frequency and conservation per position of 24–30 nt small RNAs mapping to the
genome or antigenome of BUNV S, M and L segments. Sequence is represented as DNA. (C)
Frequency distribution of the 21 nt and 24–30 nt BUNV-specific small RNAs across the antige-
nome (positive numbers and red) from the 5‘ to 3‘ and genome (negative numbers and green)
from the 3‘ to 5‘.
(TIF)
S3 Fig. Generation and characterization of recombinant BUNV or SBV expressing Nano
luciferase (BUNV-NL or SBV-NL). (A) Construction of TVT7BUNM-NL in which the cod-
ing region of the NSm cytoplasmic tail (residues 395 to 455) was replaced by that of Nano lucif-
erase (NL); BUN-NL GPC was cleaved into Gn, Gc, and NSm-NL chimeric protein. The fused
NL is shown in orange, signal peptide (sp) in the grey box and transmembrane domain (TM)
in the black box. The amino acid positions at the boundary of each protein are marked on top
of Wt BUNV GPC. (B) Comparison of protein profiles of BUNV and BUNV-NL. BSR-T7/5
cells were infected with BUNV and BUNV-NL at MOI of 0.5 and labelled with [35S]methio-
nine at 24 hours p.i for 20 hours. Viral proteins were precipitated with anti-BUNV antibody
and analysed by 12.5% SDS-PAGE tris-glycine gel under reducing conditions. Positions of
viral proteins are indicated. (C) Comparison of plaque phenotypes of BUNV and BUNV-NL
on Vero E6 cells. Cells were fixed with 4% formaldehyde-PBS and stained with 0.1% crystal
violet blue solution. (D) Immunofluorescence of Aag2 cells infected with either BUNV-NL or
SBV-NL at MOI 0.01 at 48 hours p.i. Anti-BUNV or anti-SBV N primary antibody, followed
by an anti-rabbit Alexa Fluor 488-conjugated secondary antibody (green) and nucleic acid
staining with Dapi (blue) was used.
(TIF)
S4 Fig. Growth of CVV, SBV and SATV in Aag2 cells. (A) Aag2 cells were infected with
CVV (MOI 1), SBV, or SATV (MOI 0.01) and culture supernatants were harvested at different
time points p.i. as indicated. Viral titres were determined by plaque assays on BHK-21 cells
(CVV) or CPT-Tert cells (SBV, SATV). Graphs represent one experiment performed in tripli-
cate. Error bars represent standard errors of the means (SE). (B) Aag2 cells were transfected
with dsRNA either specifically to Piwi4 or eGFP as control, followed by CVV infection at 24
hours p.t. Images of cells shown were taken at 48 hours p.i using the EVOS FL Cell Imaging
System.
(TIF)
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S1 Table. Actual deep sequencing reads for the data analysed in this study. The actual num-
bers of small RNA reads obtained in each experiment performed and analysed in this study are
outlined in the table. The total number of reads against each virus segment as well as the num-
ber of reads of each size for each repeat is shown.
(XLSX)
S2 Table. Primer sequences used in this study.
(DOC)
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